Literature DB >> 7813501

Rapid detection of cytomegalovirus infection in immunocompromised patients.

M Degré1, G Bukholm, E Holter, F Müller, H Rollag.   

Abstract

Several routinely employed diagnostic methods were analysed for their usefulness in aiding an early and rapid diagnosis of human cytomegalo-virus infection in immunocompromised patients. Clinical samples obtained during an 18-month period were examined by conventional culture, the shell vial method, detection of pp65 antigen and the polymerase chain reaction. Detection of pp65 antigen in peripheral leukocytes was the most useful method for rapid detection of infection at an early stage. Results of other rapid detection methods, the shell vial method and the polymerase chain reaction, gave useful support, while results obtained by conventional culture were not available until after the initiation of therapy. Only a small proportion of serological tests provided useful information for determining whether to treat the patient.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813501     DOI: 10.1007/bf01973997

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  Rapid detection of infectious cytomegalovirus in blood with the aid of monoclonal antibodies.

Authors:  J Schirm; W Timmerije; W van der Bij; T H The; J B Wilterdink; A M Tegzess; W J van Son; F P Schröder
Journal:  J Med Virol       Date:  1987-09       Impact factor: 2.327

2.  Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens.

Authors:  C A Gleaves; T F Smith; E A Shuster; G R Pearson
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

3.  Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method.

Authors:  W J Martin; T F Smith
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

4.  Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci.

Authors:  P D Griffiths; D D Panjwani; P R Stirk; M G Ball; M Ganczakowski; H A Blacklock; H G Prentice
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

5.  Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification.

Authors:  G J Demmler; G J Buffone; C M Schimbor; R A May
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

6.  Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients.

Authors:  M G Revello; E Percivalle; M Zavattoni; M Parea; P Grossi; G Gerna
Journal:  J Med Virol       Date:  1989-10       Impact factor: 2.327

7.  Direct detection of human cytomegalovirus in urine specimens from renal transplant patients following polymerase chain reaction amplification.

Authors:  D M Olive; S al Mufti; M Simsek; H Fayez; W al Nakib
Journal:  J Med Virol       Date:  1989-12       Impact factor: 2.327

8.  The detection of human cytomegalovirus immediate early antigen in peripheral blood leucocytes.

Authors:  G Bein; A Bitsch; J Hoyer; H Kirchner
Journal:  J Immunol Methods       Date:  1991-03-21       Impact factor: 2.303

9.  The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection.

Authors:  J M Grefte; B T van der Gun; S Schmolke; M van der Giessen; W J van Son; B Plachter; G Jahn; T H The
Journal:  J Gen Virol       Date:  1992-11       Impact factor: 3.891

10.  Comparison between viremia and antigenemia for detection of cytomegalovirus in blood.

Authors:  W van der Bij; J Schirm; R Torensma; W J van Son; A M Tegzess; T H The
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

  10 in total
  1 in total

1.  Evaluation of the murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell vial assay for diagnosis of human cytomegalovirus viremia in immunocompromised patients.

Authors:  W Y Barrett-Muir; C Aitken; K Templeton; M Raftery; S M Kelsey; J Breuer
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.